Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study-IL PSO (ITALIAN LANDSCAPE PSORIASIS).
Luigi GargiuloLuciano IbbaPiergiorgio MalagoliFabrizio AmorusoGiuseppe ArgenzianoAnna BalatoFederico BardazziMartina BurlandoCarlo Giovanni CarreraGiovanni DamianiPaolo DapavoValentina DiniChiara FranchiFrancesca Maria GaianiGiampiero GirolomoniClaudio GuarneriClaudia LasagniFrancesco LoconsoleAngelo Valerio MarzanoMartina MaurelliMatteo MegnaOrsini DiegoFrancesca SampognaMassimo TravagliniMario ValentiAntonio CostanzoAlessandra NarcisiPublished in: Journal of clinical medicine (2024)
This study supports the long-term effectiveness and safety of risankizumab in a real-world setting, even in patients involving difficult-to-treat areas.